A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2004
11/10/2004	CN1545414A Organic compounds
11/10/2004	CN1545413A Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
11/10/2004	CN1545408A Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups
11/10/2004	CN1545407A Transdermal therapeutic system (TTS) with fentanyl as active ingredient
11/10/2004	CN1545406A Water-free ubichinon concentrate
11/10/2004	CN1544638A Virus-like particle capable of carrying and loading polypeptide
11/10/2004	CN1544508A Poly acid anhydride for release-controlled medicine carrier and method for producing the same
11/10/2004	CN1544472A Branched polyethylene glycol-interferon and its making method and uses
11/10/2004	CN1544468A Polyethylene glycol-interferon connected with amido bond and its making method and uses
11/10/2004	CN1544092A Ophthalmic compositions containing galactomannan polymers and borate
11/10/2004	CN1544088A Immediate release tablet
11/10/2004	CN1544084A Prolonged delivery of peptides
11/10/2004	CN1543941A Combined sustained release agent and preparation thereof for preventing and treating livestock helminth, acarid and ectosarc disease
11/10/2004	CN1543932A Application of solid liposome nanoparticle for preparing pharmaceutical used for ion leading-in trandermal therapy
11/10/2004	CN1543931A Method for preparing brain targeting liposome pharmaceutical
11/10/2004	CN1543929A Ultrafine fibre preparation of taxol and method and apparatus for preparing the same
11/10/2004	CN1174991C O form crystal of clarithromycin
11/10/2004	CN1174775C Direct tabletting aids
11/10/2004	CN1174749C Tanshinone nanometer preparation and its preparing method
11/10/2004	CN1174747C Liquid antiacid compositions
11/10/2004	CN1174745C Use of coating as taste masking agent for oral preparation
11/10/2004	CN1174744C Thermal formed solid releasing-controlled medicinal composition
11/10/2004	CN1174743C Stabilised polyvinylpyrrdidone formulation
11/10/2004	CN1174742C Controlled release of metal cation-stabilized interferon
11/10/2004	CN1174741C Surface modified particulate compositions of biologically active substances
11/10/2004	CN1174740C Taste masked pharmaceutical liquid formulations
11/09/2004	US6815469 Injectable liquid oligomer-polymer composition consisting of at least one bioactive substance, at least one solid polymeric hydroxycarboxylic acid ester and at least one liquid oligomeric hydroxycarboxylic acid ester
11/09/2004	US6815454 Percutaneously applicable preparation and suppository containing an antidementia medicament
11/09/2004	US6815436 Hyperglycemic agents; antidiabetic agents
11/09/2004	US6815435 Pharmaceutical compositions containing DDS compounds
11/09/2004	US6815433 Composition and method for the treatment of dysglucaemia
11/09/2004	US6815424 Intranasal administration of polypeptides in powdered form
11/09/2004	US6815416 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/09/2004	US6815414 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
11/09/2004	US6814971 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a bordetella infections and/or a toxigenic pasteuralla infections
11/09/2004	US6814964 Supramolecules containing binding and therapeutic molecules bound to hybridized nucleic acids
11/09/2004	US6814955 Aerosol comprises particles of chlordiazepoxide, betahistine, clonidine, testosterone, conjugated estrogens, estrogen esters, estradiol, estradiol esters, ethinyl estradiol, ethinyl estradiol esters, or hyoscyamine.
11/09/2004	US6814954 Delivery of compounds for the treatment of Parkinsons through an inhalation route
11/09/2004	US6814953 Bronchodilating compositions and methods
11/09/2004	US6814319 Dispersing drug in a suitable volume of a liquid dispersion medium to form a suspension; bringing together in a vessel grinding media, magnetically activatable means for stirring and the suspension; magnetically activating; separation
11/09/2004	CA2317999C Pharmaceutical formulation of fluticasone propionate
11/09/2004	CA2282360C Preparation of powder agglomerates
11/09/2004	CA2138137C Diphtheria toxin vaccines
11/09/2004	CA2109572C Method for reducing side-effects of a drug
11/04/2004	WO2004094991A2 Treatment or prevention of respiratory viral infections with alpha thymosin peptides
11/04/2004	WO2004094631A1 Di-glycosil glyceryl compounds for the stabilisation and preservation of biomaterials
11/04/2004	WO2004093916A1 A medicament for the two-step perioperative therapy of solid tumours
11/04/2004	WO2004093851A1 Alpha-hydroxy acid ester drug delivery compositions and methods of use
11/04/2004	WO2004093848A2 Dry power inhaler devices and dry power formulations for enhancing dosing efficiency
11/04/2004	WO2004093845A2 Ligand-coupled initiator polymers and methods of use
11/04/2004	WO2004093823A2 Polyethelene glycol link glp-1 compounds
11/04/2004	WO2004093807A2 Somatostatin vectors
11/04/2004	WO2004093799A2 Thyroid receptor ligands
11/04/2004	WO2004093569A1 Topical composition on the basis of honey
11/04/2004	WO2004085471A3 Glp-2 derivatives
11/04/2004	WO2004084826A3 Antifungal nail coat and method of use
11/04/2004	WO2004082589A3 Nasally administrable, bioavailable pharmaceutical composition of loratadine
11/04/2004	WO2004060347A3 Pharmaceutical propylene glycol solvate compositions
11/04/2004	WO2004060346A3 Drug delivery from rapid gelling polymer composition
11/04/2004	WO2004060268A3 A method and article to control cellulite
11/04/2004	WO2004057959A3 Intracutaneous injection
11/04/2004	WO2004053192A9 Orally administered dosage forms of fused gaba analog prodrugs having reduced toxicity
11/04/2004	WO2004045549A3 Medical devices employing novel polymers
11/04/2004	WO2004035537A3 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof
11/04/2004	WO2004026259A3 Transdermal compositions
11/04/2004	WO2004020454A3 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
11/04/2004	WO2004009035A3 Compositions and products containing enantiomeric equol, and methods for their making
11/04/2004	WO2003103662A3 Inhibitors of glycoprotein vi
11/04/2004	WO2003090724A8 Coated particles with prolonged release and tablets containing same
11/04/2004	WO2003086324A3 Preparation and use of a stable formulation of allosteric effector compounds
11/04/2004	WO2003082195A3 Protamine-adenoviral vector complexes and methods of use
11/04/2004	WO2003063799A3 Compositions and methods for systemic inhibition of cartilage degradation
11/04/2004	US20040220283 Aqueous 2,6-diisopropylphenol pharmaceutical compositions
11/04/2004	US20040220276 Coated granules of allylamine-or benzylamine-anti-mycotics
11/04/2004	US20040220262 Transdermal and topical administration of drugs using basic permeation enhancers
11/04/2004	US20040220228 Freeze-dried pantoprazole preparation and pantoprazole injection
11/04/2004	US20040220205 Parkinson's disease; restless leg syndrome; sexual disorders
11/04/2004	US20040220204 mixture of fatty ester, alkylene carbonate, butylene glycol, diethylene glycol, monoalkyl ether and thickeners
11/04/2004	US20040220196 antitumor agents; 4-amino-5-fluoro-3-(6-( 4-methylpiperazin-1-yl)1H-benzimidazol-2-yl)-quinolin-2-one
11/04/2004	US20040220181 Adhesive antineoplastic compositions
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220160 fine particle sizes; topical applying; mixture with arginine, tocopherol and lecithin
11/04/2004	US20040220154 Topical testosterone formulations and associated methods
11/04/2004	US20040220143 Oral delivery of macromolecules
11/04/2004	US20040220142 Imine-forming polysaccharide adjuvants and immunostimulants
11/04/2004	US20040220121 Methods for drug delivery
11/04/2004	US20040220116 mixture with polysorbate; beverages, cosmetics, nutrient adjuvants, cleaning compounds,
11/04/2004	US20040220100 transdermal drug delivery; nucleic acids
11/04/2004	US20040220095 peptide nucleic acids; prevent gene expression; viricides
11/04/2004	US20040220086 contacting with protein which binds to cells in diseased tissue; antitumor agents
11/04/2004	US20040220085 Compositions for nucleic acid delivery
11/04/2004	US20040220083 Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body
11/04/2004	US20040219655 Nanoscale particles synthesized within an assembled virion
11/04/2004	US20040219633 Method of producing recombinant antibodies
11/04/2004	US20040219605 Fluid planar lipid layer-based membrane-anchored ligand system with defined ligand valency and methods of use thereof
11/04/2004	US20040219239 Nutritional supplement based on blackcurrent seed oil
11/04/2004	US20040219230 Compositions for preparing external carbon dioxide agents
11/04/2004	US20040219229 Migraine relief composition and methods of using and forming same
11/04/2004	US20040219223 inhibiting stenosis following vascular trauma or disease by administering antiproliferative agents or vasodilators that have little effect on protein synthesis and allow vascular repair
11/04/2004	US20040219222 Method to obtain microparticles

1 ... 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 ... 1712